Morgan Stanley’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-700
| Closed | -$945 | – | 8339 |
|
|
2025
Q1 | $945 | Hold |
700
| – | – | ﹤0.01% | 7288 |
|
|
2024
Q4 | $546 | Hold |
700
| – | – | ﹤0.01% | 7336 |
|
|
2024
Q3 | $420 | Hold |
700
| – | – | ﹤0.01% | 7319 |
|
|
2024
Q2 | $434 | Hold |
700
| – | – | ﹤0.01% | 7243 |
|
|
2024
Q1 | $580 | Sell |
700
-4,700
| -87% | -$3.89K | ﹤0.01% | 7226 |
|
|
2023
Q4 | $3.78K | Buy |
5,400
+2,700
| +100% | +$1.89K | ﹤0.01% | 7049 |
|
|
2023
Q3 | $3.24K | Hold |
2,700
| – | – | ﹤0.01% | 7013 |
|
|
2023
Q2 | $8.51K | Hold |
2,700
| – | – | ﹤0.01% | 6865 |
|
|
2023
Q1 | $9.02K | Hold |
2,700
| – | – | ﹤0.01% | 6913 |
|
|
2022
Q4 | $10.9K | Buy |
2,700
+200
| +8% | +$810 | ﹤0.01% | 6897 |
|
|
2022
Q3 | $9K | Hold |
2,500
| – | – | ﹤0.01% | 7125 |
|
|
2022
Q2 | $9K | Hold |
2,500
| – | – | ﹤0.01% | 7255 |
|
|
2022
Q1 | $14K | Buy |
2,500
+1,700
| +213% | +$9.52K | ﹤0.01% | 7291 |
|
|
2021
Q4 | $5K | Buy |
+800
| New | +$5K | ﹤0.01% | 7658 |
|